Chemed (CHE) Change in Accured Expenses (2009 - 2026)

Chemed has reported Change in Accured Expenses for 18 years, with the latest figure at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 605.47% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $16.2 million (up 56.08% YoY), and the FY2025 full-year result was $10.4 million, down 54.18% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $6.7 million, up from $4.1 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $13.3 million in Q1 2024, with the low at -$5.1 million in Q3 2022.
• Average Change in Accured Expenses over 5 years is $2.9 million, with a median of $3.0 million recorded in 2022.
• Year-over-year, Change in Accured Expenses sank 249.56% in 2022 and surged 605.47% in 2026.
• Tracing CHE's Change in Accured Expenses over 5 years: stood at $3.2 million in 2022, then tumbled by 57.07% to $1.4 million in 2023, then soared by 219.84% to $4.4 million in 2024, then fell by 7.54% to $4.1 million in 2025, then soared by 64.88% to $6.7 million in 2026.
• The last three Change in Accured Expenses figures came in at $6.7 million (Q1 2026), $4.1 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.

Peer Comparison